BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 31520268)

  • 1. A newly found homozygous mutation in recombination activating gene 1 in a patient with leaky severe combined immunodeficiency disorder.
    Salari F; Zaremehrjardi F; Arshi S; Bemanian MH; Fallahpour M; Shokri S; Seif F; Movahedi M; Nabavi M
    Mol Biol Rep; 2019 Dec; 46(6):6571-6575. PubMed ID: 31520268
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phenotypical heterogeneity in RAG-deficient patients from a highly consanguineous population.
    Meshaal SS; El Hawary RE; Abd Elaziz DS; Eldash A; Alkady R; Lotfy S; Mauracher AA; Opitz L; Pachlopnik Schmid J; van der Burg M; Chou J; Galal NM; Boutros JA; Geha R; Elmarsafy AM
    Clin Exp Immunol; 2019 Feb; 195(2):202-212. PubMed ID: 30307608
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Similar recombination-activating gene (RAG) mutations result in similar immunobiological effects but in different clinical phenotypes.
    IJspeert H; Driessen GJ; Moorhouse MJ; Hartwig NG; Wolska-Kusnierz B; Kalwak K; Pituch-Noworolska A; Kondratenko I; van Montfrans JM; Mejstrikova E; Lankester AC; Langerak AW; van Gent DC; Stubbs AP; van Dongen JJ; van der Burg M
    J Allergy Clin Immunol; 2014 Apr; 133(4):1124-33. PubMed ID: 24418478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A variant of RAG1 gene identified in severe combined immunodeficiency: a case report.
    Zhang X; Kang X; Yang M; Cai Z; Song Y; Zhou X; Cao J; Wang C; Huang K; Peng Y; He J; Xiao Z
    BMC Pediatr; 2023 Feb; 23(1):56. PubMed ID: 36732712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oligoclonal expansion of T lymphocytes with multiple second-site mutations leads to Omenn syndrome in a patient with RAG1-deficient severe combined immunodeficiency.
    Wada T; Toma T; Okamoto H; Kasahara Y; Koizumi S; Agematsu K; Kimura H; Shimada A; Hayashi Y; Kato M; Yachie A
    Blood; 2005 Sep; 106(6):2099-101. PubMed ID: 15845893
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel homozygous
    Melika S; Hossein E; Mona S; Elham R; Samaneh Z; Sepideh S; Raul Jimenez H; Ana K; Kaan B; Nima R
    Allergol Immunopathol (Madr); 2021; 49(4):91-97. PubMed ID: 34224223
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A systematic analysis of recombination activity and genotype-phenotype correlation in human recombination-activating gene 1 deficiency.
    Lee YN; Frugoni F; Dobbs K; Walter JE; Giliani S; Gennery AR; Al-Herz W; Haddad E; LeDeist F; Bleesing JH; Henderson LA; Pai SY; Nelson RP; El-Ghoneimy DH; El-Feky RA; Reda SM; Hossny E; Soler-Palacin P; Fuleihan RL; Patel NC; Massaad MJ; Geha RS; Puck JM; Palma P; Cancrini C; Chen K; Vihinen M; Alt FW; Notarangelo LD
    J Allergy Clin Immunol; 2014 Apr; 133(4):1099-108. PubMed ID: 24290284
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel RAG1 mutation and the occurrence of mycobacterial and Chromobacterium violaceum infections in a case of leaky SCID.
    Khan TA; Iqbal A; Rahman H; Cabral-Marques O; Ishfaq M; Muhammad N
    Microb Pathog; 2017 Aug; 109():114-119. PubMed ID: 28552805
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The immunophenotypic and immunogenotypic B-cell differentiation arrest in bone marrow of RAG-deficient SCID patients corresponds to residual recombination activities of mutated RAG proteins.
    Noordzij JG; de Bruin-Versteeg S; Verkaik NS; Vossen JM; de Groot R; Bernatowska E; Langerak AW; van Gent DC; van Dongen JJ
    Blood; 2002 Sep; 100(6):2145-52. PubMed ID: 12200379
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic mutations and immunological features of severe combined immunodeficiency patients in Iran.
    Shahbazi Z; Yazdani R; Shahkarami S; Shahbazi S; Hamid M; Sadeghi-Shabestari M; Momen T; Aleyasin S; Esmaeilzadeh H; Darougar S; Delavari S; Mahdaviani SA; Ahanchian H; Behmanesh F; Kiaee F; Chavoshzade Z; Shariat M; Keramatipour M; Rezaei N; Abolhassani H; Parvaneh N; Mahdian R; Aghamohammadi A
    Immunol Lett; 2019 Dec; 216():70-78. PubMed ID: 31589898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Partial correction of immunodeficiency by lentiviral vector gene therapy in mouse models carrying
    Castiello MC; Di Verniere M; Draghici E; Fontana E; Penna S; Sereni L; Zecchillo A; Minuta D; Uva P; Zahn M; Gil-Farina I; Annoni A; Iaia S; Ott de Bruin LM; Notarangelo LD; Pike-Overzet K; Staal FJT; Villa A; Capo V
    Front Immunol; 2023; 14():1268620. PubMed ID: 38022635
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombination-activating gene 1 (Rag1)-deficient mice with severe combined immunodeficiency treated with lentiviral gene therapy demonstrate autoimmune Omenn-like syndrome.
    van Til NP; Sarwari R; Visser TP; Hauer J; Lagresle-Peyrou C; van der Velden G; Malshetty V; Cortes P; Jollet A; Danos O; Cassani B; Zhang F; Thrasher AJ; Fontana E; Poliani PL; Cavazzana M; Verstegen MM; Villa A; Wagemaker G
    J Allergy Clin Immunol; 2014 Apr; 133(4):1116-23. PubMed ID: 24332219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical, immunologic, and genetic characteristics of RAG mutations in 15 Chinese patients with SCID and Omenn syndrome.
    Bai X; Liu J; Zhang Z; Liu C; Zhang Y; Tang W; Dai R; Wu J; Tang X; Zhang Y; Ding Y; Jiang L; Zhao X
    Immunol Res; 2016 Apr; 64(2):497-507. PubMed ID: 26476733
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical characteristics of human recombination activating gene 1 mutations in 8 immunodeficiency patients with diverse phenotypes].
    Yu G; Wang WJ; Liu DR; Tao ZF; Hui XY; Hou J; Sun JQ; Wang XC
    Zhonghua Er Ke Za Zhi; 2018 Mar; 56(3):186-191. PubMed ID: 29518828
    [No Abstract]   [Full Text] [Related]  

  • 15. Three faces of recombination activating gene 1 (RAG1) mutations.
    Patiroglu T; Akar HH; Van Der Burg M
    Acta Microbiol Immunol Hung; 2015 Dec; 62(4):393-401. PubMed ID: 26689875
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of anti-herpes simplex virus antibody-producing B cells in a patient with an atypical RAG1 immunodeficiency.
    Kumaki S; Villa A; Asada H; Kawai S; Ohashi Y; Takahashi M; Hakozaki I; Nitanai E; Minegishi M; Tsuchiya S
    Blood; 2001 Sep; 98(5):1464-8. PubMed ID: 11520796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generation of recombination activating gene-1-deficient neonatal piglets: a model of T and B cell deficient severe combined immune deficiency.
    Ito T; Sendai Y; Yamazaki S; Seki-Soma M; Hirose K; Watanabe M; Fukawa K; Nakauchi H
    PLoS One; 2014; 9(12):e113833. PubMed ID: 25437445
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leaky severe combined immunodeficiency and aberrant DNA rearrangements due to a hypomorphic RAG1 mutation.
    Giblin W; Chatterji M; Westfield G; Masud T; Theisen B; Cheng HL; DeVido J; Alt FW; Ferguson DO; Schatz DG; Sekiguchi J
    Blood; 2009 Mar; 113(13):2965-75. PubMed ID: 19126872
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heterogeneity in RAG1 and RAG2 deficiency: 35 cases from a single-centre.
    Karaatmaca B; Cagdas D; Esenboga S; Erman B; Tan C; Turul Ozgur T; Boztug K; van der Burg M; Sanal O; Tezcan I
    Clin Exp Immunol; 2024 Feb; 215(2):160-176. PubMed ID: 37724703
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular analysis of T-B-NK+ severe combined immunodeficiency and Omenn syndrome cases in Saudi Arabia.
    Alsmadi O; Al-Ghonaium A; Al-Muhsen S; Arnaout R; Al-Dhekri H; Al-Saud B; Al-Kayal F; Al-Saud H; Al-Mousa H
    BMC Med Genet; 2009 Nov; 10():116. PubMed ID: 19912631
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.